ARCB Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
ArcBest Corp (ARCB) is not a strong buy at the moment for a beginner investor with a long-term strategy. The lack of positive financial performance, neutral technical indicators, and absence of strong trading signals suggest waiting for more favorable conditions before investing.
The MACD is below 0 and negatively contracting (-1.475), indicating weak momentum. RSI is neutral at 50.351, and moving averages are converging, showing no clear trend. The price is near a key pivot point (102.333), with resistance at 107.359 and support at 97.307.
Insider buying has increased by 284.68% over the last month, indicating confidence from company insiders.
The company's Q4 financials show a significant decline in revenue (-2.89% YoY), net income (-127.95% YoY), and EPS (-129.27% YoY). Gross margin also dropped by 2.30% YoY. Analysts' ratings are mostly neutral, with no significant upgrades. No recent news or congress trading data is available.
In Q4 2025, ArcBest reported a revenue decline to $972.7M (-2.89% YoY), a net income loss of -$8.12M (-127.95% YoY), and an EPS drop to -$0.36 (-129.27% YoY). Gross margin decreased to 80.83 (-2.30% YoY), reflecting weak financial performance.
Analysts have mixed views. Recent price target changes include BofA raising the target to $105 (Neutral), Citi raising it to $105 (Buy), and Stifel lowering it to $94 (Buy). Most analysts maintain Neutral ratings, with no strong consensus for a buy.
